| Sarcoidosis |
1 |
1 |
| Clinical Guidelines |
0 |
0.99 |
| Treatment Guidelines |
0 |
0.98 |
| Fatigue |
0 |
0.13 |
| Lung |
0 |
0.13 |
| Thorax |
0 |
0.13 |
| Tissue |
0 |
0.13 |
| Health Care Reform |
0 |
0.8 |
| Social Determinants of Health |
0 |
0.09 |
| Adverse Effects |
0 |
0.06 |
| Corticosteroids |
0 |
0.06 |
| Dyspnea |
0 |
0.06 |
| Europe |
0 |
0.06 |
| Evidence-Based Medicine |
0 |
0.06 |
| Fellowship |
0 |
0.06 |
| Grant |
0 |
0.06 |
| Health Care Quality, Access, and Evaluation |
0 |
0.75 |
| Heart |
0 |
0.06 |
| Maryland |
0 |
0.06 |
| Outpatient Clinic |
0 |
0.06 |
| Patient Safety |
0 |
0.06 |
| Plain Radiography |
0 |
0.06 |
| Prognosis |
0 |
0.06 |
| Referral |
0 |
0.06 |
| Remission |
0 |
0.06 |
| Revenue and Practice Management |
0 |
0.6 |
| Salary and Compensation |
0 |
0.06 |
| Steroids |
0 |
0.06 |
| Ultrasonography |
0 |
0.06 |